Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients

Journal of the Medical Association of Thailand

Volumn 85, Issue 7, 2002, Pages 757-764

  Bussaratid, Valai ^a   Tansupasawasdikul, Somsit ^b   Simpson, Andrew ^a   Pitisuttithum, Punnee ^a   Phonrat, Benjaluck ^a   Howe, Paul ^a   White, Nicholas J ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Bamrasnaradura Hospital   (Thailand)

Author keywords

HIV Infection; Oropharyngeal Candidiasis

Indexed keywords

FLUCONAZOLE;

ADULT; ARTICLE; CANDIDA; CANDIDIASIS; DRUG EFFECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUTHWASH; MYCOLOGY; OPPORTUNISTIC INFECTION; OROPHARYNX; PREDICTION; PROSPECTIVE STUDY; SPECIES DIFFERENTIATION;

ADULT; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; FEMALE; FLUCONAZOLE; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; OROPHARYNX;

EID: 14244271458     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Weekly epidemiological surveillance report: Division of Epidemiology. Ministry of Public Health 1997; 28: 690.
2. Deborah G, John SG. HIV related oral disease. Lancet 1996; 348: 729-32.
3. Feigel DW, Kotz MH, Greenspan D, et al. The prevalence of oral lesions in HIV infected homosexual and bisexual men: Three San Francisco epidemiological cohorts. AIDS 1991; 5: 519-25.
4. Teanpaisan R, Nitlayananta W. Prevalence of Candida species in AIDS patients and HIV-free subjects in Thailand. J Oral Pathol Med 1998; 27: 4-7.
5. Darrouiche RO. Oropharyngeal and Esophageal Candidiasis in Immunocompromised patients: Treatment Issues. Clin Infect Dis 1998; 26: 259-74.
6. Dronda F, Alonsi-Sanz M, Laguna F, et al. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1996; 15: 446-52.
7. Phillips P, De Beule K, Frechette G, et al. A double blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS. Clin Infect Dis 1998; 26: 1368-73.
8. Hoegl L, Thoma-Greber E, Rocken M, Korting HC. Persistent oral candidosis by non-albicans Candida strains including Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of 6 years. Mycoses 1998; 41: 335-8.
9. Powderly WG, Gallant JE, Ghannoum MA, Mayer KH, Navarro EE, Perfect JR. Oropharyngeal candidiasis in patients with HIV: Suggested guidelines for therapy. AIDS Res Hum Retroviruses 1999; 15: 1619-23.
10. Rex JH, Walsh TJ, Sobel JD, et al. Practice Guidelines for the Treatment of candidiasis. CID 2000; 30: 662-78.
11. Martins MD, Lozano-Chiu M, Rex JH. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients. Clin Infect Dis 1998; 27: 1291-4.
12. Magaldi S, Mata S, Hartung C, et al. In vitro susceptibility of 137 Candida spp. Isolates from HIV positive patients to several antifungal drugs. Mycopathologia 2001; 149: 63-8.
13. Hoegl L, Thoma-Greber E, Rocken M, Korting HC. Persistent oral candidiasis by non-albicans Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of years. Mycoses 1998; 41: 335-8.
14. Schuman P, Sobel JD, Ohmit SE, et al. Mucosal Candidal colonization and candidiasis in woman with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) group. Clin Infect Dis 1998; 27: 1161-7.
15. Revankar SG, Kirkpatrick WC, Dib-OP, et al. Detection and significance of fluconazole resistance in oropharyngeal candidiasis in HIV-infected patients. J Infect Dis 1996; 174: 821-7.
16. Chryssanthon E, Torssander J, Petrin B. Oral Candida albican isolates with reduced susceptibility to fluconazole in Swedish HIV Infected patients. Scan J Infect Dis 1995; 27: 391.
17. Bergbrant IM, Faergemann J. Quantitative cultures of Candida from mouthwash fluid in HIV-infected patients: A longitudinal study. Mycoses 1997; 40: 377-80.
18. th ed. Thailand: Ministry of Public Health, 2000: 175.
19. Diz Dios P, Ocampo A, Otero I, Iglesias I, Martinez C. Changes in oropharyngeal colonization and infection by Candida albicans in human immunodeficiency virus-infected patients. J Infect Dis 2001; 183: 355-6.
20. Masia CM, Gutierrez RF, Ortiz de la Tabla DV, et al. Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients. Eur J Clin Microbiol Infect Dis 2000; 19: 593-601.
21. Walmsley S, King S, Mcgear A, Ye Y, Richardson S. Oropharyngeal candidiasis in patients with human immunodeficiency virus : Correlation of clinical outcome with in vitro resistance, Serum Azole Levels and Immunosuppression. CID 2001; 32: 1554-61.
22. Arikan S, Akova M, Haysan M, et al. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with OPC. Clin Infect Dis 1998; 26: 903-8.